U.S. Software Stock News

Wondering if Rumble’s stock price is a hidden bargain or a red flag? Let’s break it down together with a focus on what really drives value. After a sharp jump of 24.3% over the past week, Rumble shares still show a year-to-date drop of 45.5%, making it one of the more volatile names in the media space. The buzz around Rumble is largely due to its ongoing positioning as a “free speech” video platform, its continued attempts to attract high-profile creators, and recent headlines about...

Wondering if Weibo stock is a hidden bargain or a value trap? Let’s quickly unpack what’s been happening and where it might go from here. Weibo’s share price moved up 0.9% over the last week, but it’s still down 14.4% over the past month, keeping investors alert to both growth potential and risks. Recent headlines have spotlighted renewed interest in Chinese tech stocks amid regulatory shifts and fresh partnership announcements from industry players. This backdrop of evolving sentiment is...

MGIC Investment recently drew market attention after reporting early signs of improvement in the U.S. mortgage market, including declining mortgage rates, better housing inventory, and increasing purchase applications. A unique aspect of the announcement is the company’s continued commitment to share repurchases, signaling strong management confidence and a focus on returning capital to shareholders. We'll examine how management’s decision to maintain significant share buybacks could...

Kura Oncology recently attracted attention after KOMZIFTI, its once-daily oral menin inhibitor, secured full FDA approval for adults with relapsed or refractory acute myeloid leukemia with a susceptible NPM1 mutation. This milestone addresses a treatment gap in AML care. See our latest analysis for Kura Oncology. Kura Oncology’s momentum has picked up meaningfully after KOMZIFTI’s approval, with the share price up over 48% in the past three months and 38% year-to-date. While recent investor...

Thinking about whether Haemonetics is a savvy investment right now? Let’s dive into what the market is signaling and where the opportunity may lie for new and existing investors. Haemonetics’ stock has seen notable swings recently, soaring 57.7% over the last month and climbing 7.4% just this past week. These moves draw attention when considering both growth and evolving risk perceptions. The recent price surge comes on the back of news highlighting the company’s expansion in innovative...

If you have ever wondered whether Hawkins is a hidden bargain or trading at a premium, you are in the right place. Let's break down what really matters when assessing value. Shareholders have seen a rollercoaster lately, with the stock jumping 5.1% over the last week but still down 22.7% in the past month. Over the long haul, Hawkins has posted a massive 442.0% return across five years. In the past few weeks, Hawkins has attracted attention thanks to industry partnerships and strategic...

Arhaus (ARHS) has attracted attention following recent trading activity, as shares saw moderate gains over the past week. Investors seem to be weighing the company's steady position in the home furnishings sector in light of broader market shifts. See our latest analysis for Arhaus. Arhaus’s recent share price jump, capped by an impressive 18% return over the last week, has caught the eye of investors. While the 1-year total shareholder return sits at a modest 3.8%, momentum appears to be...

Wondering if W. R. Berkley is trading at a bargain or getting pricey? Let’s dig into what’s really driving its value right now. The stock is on the move, climbing 1.2% over the past week and an impressive 33.8% year-to-date. This hints at renewed investor optimism or changing risk appetites. Much of this momentum has been fueled by upbeat industry-wide outlooks and W. R. Berkley’s recent moves to expand its specialty insurance offerings. These developments have caught investor attention and...

Even though Intuit Inc.'s ( NASDAQ:INTU ) recent earnings release was robust, the market didn't seem to notice. Our...

Wondering if LTC Properties is currently a good value or just another stock story? You are not alone, and understanding where it stands today could make a real difference for your portfolio. Shares have been quietly ticking upward, rising 2.1% over the past week and 7.5% so far this year. This hints at renewed interest and possibly shifting risk perceptions in the market. There has also been heightened chatter around regulatory updates and portfolio acquisitions, which are fueling optimism...

MSA Safety (MSA) has recently seen some movement in its stock price, prompting investors to take a closer look at its performance in recent months. A quick check of the numbers helps frame its recent trajectory. See our latest analysis for MSA Safety. After a volatile year, MSA Safety’s share price is down from recent highs and its one-year total shareholder return sits at -6.5%. Despite some shorter-term pressure, the bigger picture looks steadier with an 18% total return for shareholders...

NIO (NYSE:NIO) has just posted its Q3 2025 results, reporting revenue of ¥21.8 billion and a basic EPS loss of -¥1.51. Looking back, the company has seen revenue climb from ¥17.4 billion in Q2 2024 to ¥21.8 billion this quarter, while EPS loss per share has ranged between -¥1.51 in Q3 2025 and -¥3.45 in Q4 2024. While NIO’s top-line numbers look sizable on paper, margins remain pressured and the profitability story is still playing out for investors. See our full analysis for NIO. Now, let's...

Are you wondering whether WSFS Financial is currently a bargain, or if it's time to cash in? You're definitely not alone. Valuing a stock goes beyond just looking at the price tag. WSFS Financial’s shares have climbed 4.4% over the past week and are up 8.6% year-to-date, showing renewed optimism in the company after a rocky previous 12 months. Recent news has centered on the company’s ongoing regional expansion and positive developments in its banking technology initiatives. These factors...

Ever wondered if Atlantic Union Bankshares is trading for less than what it’s really worth? If you’re curious about snapping up a value play, you’re in the right place. This stock has made some notable moves lately, rising 5.5% over the past week but still down 7.9% so far this year. This pattern points to changing market sentiment or renewed optimism after a challenging stretch. Investors recently reacted to sector-wide news about regulatory clarity and shifting interest rates. Both of...

Ever wondered if McKesson’s rapid ascent means it is still a good buy, or if the best opportunities are already in the rearview mirror? In just the past year, McKesson’s stock jumped a striking 41.7%, with especially strong gains of 3.7% in the last week and 8.9% over the past month. This hints at both momentum and increased market attention. Recent headlines have been filled with updates on McKesson’s expansion of its specialty drug distribution and an industry-wide interest in healthcare...

Thinking about ICON and whether its current price offers value? You are not alone, especially if you are trying to figure out if now is an opportunity or a risk for your portfolio. ICON’s stock has made some noise recently, jumping 15.6% over the last week, which has interrupted a longer-term slide with returns of -13.6% year-to-date and -13.7% over the past year. Recent headlines highlight regulatory developments in the healthcare sector and renewed optimism around biotech funding. Both...

Ever wondered if CareTrust REIT is truly a bargain or just getting started? You're not alone. With investor excitement rising, it’s the perfect time to ask. Shares have gained 41.2% year-to-date and have delivered a 136.5% total return over five years, which may indicate renewed growth or changing risk perceptions. Much of this momentum follows CareTrust REIT’s strategic acquisitions and expansion plans in the senior housing and healthcare real estate sectors. This signals management’s...

Wondering if Sarepta Therapeutics is finally trading at a bargain price? You are not alone, as savvy investors often watch for signs the stock might be undervalued. Sarepta’s share price has surged 27.8% in just the last week, but despite that jump, it is still down almost 85% over the past year. This volatility hints at changing risk perceptions and possible upside. Recent headlines highlight Sarepta’s FDA approval for a key gene therapy, which has revitalized sentiment and contributed...

Ever wondered if e.l.f. Beauty’s stock is actually a bargain, or just another name riding the waves of market hype? You are not alone in wanting a clear answer to whether its current price truly makes sense. The stock has shown serious movement lately, with a recent 5.6% jump over the last week. This follows a choppy 40.4% drop in the last month and a 38.8% slide year-to-date. The longer term three- and five-year returns still stand at 36.9% and an eye-catching 234.5% respectively. Investors...

In the past week, Pediatrix Medical Group reported third quarter revenues surpassing analyst forecasts by 3.2%, supported by improved collections, higher patient acuity, and a favorable payor mix, despite a year-over-year revenue decline. An additional boost to the outlook came as the White House proposed a two-year extension of key Obamacare subsidies, a policy seen as crucial for healthcare providers targeting the ACA marketplace. We'll explore how strong collection activity and policy...

International Flavors & Fragrances Inc. ( NYSE:IFF ) has announced that it will pay a dividend of $0.40 per share on...

The board of Liberty Energy Inc. ( NYSE:LBRT ) has announced that it will be paying its dividend of $0.09 on the 18th...

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...

EHang Holdings (NasdaqGM:EH) just announced its Q3 2025 financial results, posting total revenue of 92.5 million CNY and a basic EPS of -1.11 CNY for the quarter. Looking at the bigger picture, the company has seen revenue move from 26.1 million CNY in Q1 2025 to 92.5 million CNY in Q3, while EPS has remained negative throughout. Despite strong top-line momentum, margins remain under pressure as losses have persisted over recent quarters. See our full analysis for EHang Holdings. Next, we...